MET and cancer: Gene expression analysis showed that the levels of cancer stem cell and EMT markers ABCG2, CD133 and c-MET significantly increased after chemotherapy treatment and were impaired by HH-GLI inhibition and the combination of 5-FU and GANT61 (Figure 5B).